Search for: "Myriad Genetic Laboratories" Results 41 - 60 of 155
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2013, 6:17 am by Marissa Miller
Myriad Genetics, in which the Justices are considering whether human genes are patentable. [read post]
12 Apr 2013, 9:29 am by Rahul Bhagnari, ACLU
The price for a BRCA screening by Myriad Genetics is $3,000 whereas any of the hundreds of clinical laboratories around the country could and would perform the test for under $200. [read post]
22 Aug 2022, 9:15 am by Eileen McDermott
Myriad Genetics, Inc., 133 S.Ct. 2107 (2013) and Mayo Collaborative Services v. [read post]
22 Aug 2022, 9:15 am by Eileen McDermott
Myriad Genetics, Inc., 133 S.Ct. 2107 (2013) and Mayo Collaborative Services v. [read post]
29 Mar 2013, 7:25 am by Rahul Bhagnari, ACLU
As a result of its patents on the genes, Myriad has forced all other laboratories in the U.S. to stop sequencing these genes when providing patients with their own genetic information, even when those laboratories would use different, more comprehensive, or lower priced testing methods. [read post]
18 May 2009, 12:49 pm
Patent and Trademark Office, patent owner Myriad Genetics, and directors of the University of Utah Research Foundation. [read post]
4 Sep 2012, 7:09 am
In An Isolated Gene Shell Myriad is the exclusive licensee of patents regarding the genetic basis of BRCA related breast and ovarian cancers and provides BRCA diagnostic testing services to women. [read post]
Myriad Genetics – the lawsuit filed by the ACLU on behalf of 20 scientific and health organizations, geneticists, and patients against patent holders Myriad and the University of Utah. [read post]
9 May 2013, 9:22 am by Benjamin Jackson
Myriad Genetics is whether the BRCA patents are good for innovation and ultimately for patients. [read post]
18 Jun 2014, 8:50 am by Doug Bucklin
Myriad Genetics, Inc., et al., changed the way many patent applications should be drafted. [read post]
13 Jun 2013, 8:35 am by Rahul Bhagnari, ACLU
And because cDNA is not required for genetic testing, laboratories will now be able to offer testing of the BRCA genes to their patients. [read post]
23 Aug 2011, 1:03 pm
On appeal to the Federal Circuit, Myriad argued that the lower court incorrectly applied the machine-or-transformation test in light of Prometheus Laboratories, Inc. v. [read post]